openPR Logo
Press release

Global Breast Cancer Drugs Market Industry Size, Share, Growth and Forecast To 2025

05-08-2020 12:19 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Rising prevalence of breast cancers globally is soaring the global breast cancer drugs market size. As per the World Health Organization, in 2018, breast cancer had the largest number of new cancer incidences. In 2018, the reported number of new breast cancer incidences were 234,087, which accounted for 11% of all new cancer incidences. As of January 2019, there were 16.9 million survivors in the US, which is expected to reach 21.7 million by 2029 (National Cancer Institute). Radiation therapy is one of the primarily used treatments for cancer. It can be given to cure cancer, either alone or in combination with surgery and/or chemotherapy. Breast, lung, and prostate cancer patients consist of over half of all patients receiving radiation therapy.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/breast-cancer-drugs-market

Increasing FDA approvals for personalized medicine is further promising ample growth opportunities for the market

The increasing adoption of personalized medicines for cancer treatment is furthermore augmenting the growth of the breast cancer drugs market. Increasing FDA approvals for personalized medicines are supporting to drive the growth of the market in the region. For instance, as per the Personalized Medicine Coalition, in 2018, 25 of the 59 new molecular entities (NMEs) FDA approved are personalized medicines, which is 42% of all new drug approvals. The coalition classified 34% of NMEs as personalized medicines in 2017, 28% in 2015; 27% in 2016. A significant number of cancer precision medicines approved in 2018, which includes biosimilars, Truxima (rituximab-abbs) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin lymphoma (NHL), and Herzuma (trastuzumab-pkrb), as a biosimilar to Herceptin for the treatment of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer and metastatic gastric cancer.

A Full Report of Global Breast Cancer Drugs Market is Available at: https://www.omrglobal.com/industry-reports/breast-cancer-drugs-market

Asia-Pacific to gain maximum traction over the forecast period

Asia-Pacific is expected to witness the fastest growth rate in the global breast cancer industry over the forecast period. Increasing prevalence of breast cancer coupled with the improving healthcare infrastructure is influencing the regional market growth. The increasing number of breast cancer patients reflects the need for the therapies including drugs for the treatment of breast cancer. As per American Cancer Society, breast cancer, lung and bronchus cancer, stomach cancer, colorectum cancer, and esophagus cancer are the most common cancer diagnosed in women, accounting for around 60% of all cases in China. Moreover, 15% of all new cancer incidences in women accounted for breast cancer, making it the most severe health condition for women in China.

Further, according to the Indian Council of Medical Research, around 1.7 million new cases of cancer are expected to emerge that are projected to take over 800,000 lives by 2020. The major mortalities in India is due to cancer which constitutes to Lung and oral among males and breast and cervix in females. Breast cancer in females accounts for more than 50% of all cancer deaths in India. Breast cancer is most prevalent in women with oral cancer being more common in males. The north-eastern states of India reported the maximum number of cancer cases. As per National Institute of Cancer Prevention and Research (NICPR), the breast cancer cases reported in India accounted to 10% of all cancers that was around 150,000 new incidences in 2016,

Current Market Trends Covered in the Global Breast Cancer Drugs Market Report

Based on the drug class type, the immunotherapy segment is estimated to hold a significant market share during the forecast period.
Based on the geography, North America is estimated to dominate the global breast cancer drugs market during the forecast period.
Asia-Pacific is anticipated to register the fastest growth in the global breast cancer drugs industry during the forecast period.

Global Breast Cancer Drugs Market Segmentation

By Drug Class Type

Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy

Global Breast Cancer Drugs Market - Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/breast-cancer-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Breast Cancer Drugs Market Industry Size, Share, Growth and Forecast To 2025 here

News-ID: 2039002 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For